5α-reductase inhibitory and antiandrogenic activities of novel steroids in hamster seminal vesicles

Chemical and Pharmaceutical Bulletin

Volumn 50, Issue 11, 2002, Pages 1447-1452

  Cabeza, Marisa ^b   Bratoeff, Eugene ^a   Flores, Eugenio ^a   Ramírez, Elena ^a   Calleros, Jorge ^a   Montes, Diana ^a   Quiroz, Alexandra ^b   Heuze, Ivonne ^b  

^a Universidad Nacional Autonoma de Mexico Facultad de Quimica   (Mexico)

^b DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

Author keywords

5 reductase; 5 reduction; Androgen receptor; C 16 substituent; Seminal vesicle; T to DHT conversion

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; ANTIANDROGEN; ENZYME INHIBITOR; OXIDOREDUCTASE; STEROID; STEROID 5ALPHA REDUCTASE;

ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME ACTIVITY; GONADECTOMY; HAMSTER; IN VITRO STUDY; MALE; NONHUMAN; ORGAN WEIGHT; RECEPTOR AFFINITY; RECEPTOR BINDING; SEMINAL VESICLE; SUBSTITUTION REACTION; ANIMAL; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; METABOLISM;

ANDROGEN ANTAGONISTS; ANIMALS; CRICETINAE; ENZYME INHIBITORS; MALE; SEMINAL VESICLES; STEROIDS; TESTOSTERONE 5-ALPHA-REDUCTASE;

EID: 0036835442     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.50.1447     Document Type: Article

References (17)

1. Bruchovski N., Wilson J. D., J. Biol. Chem., 243, 2012-2021 (1968).
2. Metcalf W. B., Levy M. A., Holt D. A., Trends Pharmacol Sciences, 10, 491-495 (1989).
3. Imperato-McGinley J., Guerrero L., Gautier T., Peterson R. E., Science, 27, 1213-1215 (1974).
4. Imperato-McGinley J., Peterson R. E., Leshin M., Griffin J. E., Cooper G., Draghi S., Berenyi M., Wilson J. D., J. Clin. Endocrinol. Metab., 50, 15-22 (1980).
5. Wilbert D. M., Griffin J. E., Wilson J. D., J. Clin. Endocrinol. Metab., 56, 113-120 (1983).
6. Weisser H., Tunn S., Debus M., Krieg M., Steroids, 59, 616-620 (1994).
7. Brooks J. R., Berman C., Primka R. L., Reynolds G. F., Rasmusson G. H., Steroids, 47, 1-19 (1986).
8. McConnel J., Wilson J. D., George F. J., J. Clin. Endocrinol. Metab., 25, 505-509 (1992).
9. Cabeza M., Gutierrez E., Miranda R., Heuze I., Bratoeff E., Flores G., Ramirez E., Steroids, 64, 413-421 (1999).
10. Cabeza M., Quiroz A., Bratoeff E., Murillo E., Ramirez E., Flores G., Chem. Pharm. Bull., 47, 1232-1236 (1999).
11. Ramírez E., Cabeza M., Heuze I., Gutiérrez E., Bratoeff E., Membrillo M., Lira A., Chem. Pharm. Bull., 50, 15-20 (2002).
12. Bradford M. M., Anal. Biochem., 72, 248-254 (1986).
13. Cabeza M., Vilchis F., Lemus A. E., Díaz de León L., Pérez-Palacios G., Steroids, 60, 630-635 (1995).
14. Scatchard G., Ann. N.Y. Acad. Sci., 52, 660-672 (1949).
15. Cabeza M., Heuze I., Bratoeff E., Ramirez E., Martinez R., Chem. Pharm. Bull., 49, 525-530 (2001).
16. Bratoeff E., Herrera H., Ramirez E., Solorzano K., Murillo E., Quiroz A., Cabeza M., Chem. Pharm. Bull., 48, 1249-1255 (2000).
17. Cheng Y. C., Prusoff W. H., Biochem. Pharmacol., 22, 3099-3108 (1973).